A Texas resident claims she was misled by alleged false statements about Invokana safety.

She seeks to hold the drug makers responsible for the injuries she sustained as a result of the taking the diabetes treatment drug.

Plaintiff Cecilia P. began taking Invokana in March 2014 for the treatment of diabetes.  She continued to use the diabetes medication until August 2015.

As a result of using Invokana, Cecilia suffered diabetic ketoacidosis with hospitalization in October 2014.

She alleges that she relied on false statements about Invokanaand that the drug caused her to sustain severe and permanent personal injuries, pain, suffering and emotional distress.

Her husband, Peter joins the lawsuit with a loss of consortium claim.

The couple is seeking compensatory, punitive, exemplary damages for Johnson & Johnson’s “wanton, willful, fraudulent, reckless acts of the Defendants who demonstrated a complete disregard and reckless indifference for the safety and welfare of the general public.”

They are requesting a trial by jury for this case.

Possible False Statements About Invokana Safety

In 2013, Johnson & Johnson introduced the diabetes drug Invokana to the market. Invokana was the first member of a new class of diabetes drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors – a drug designed to work by inhibiting some kidney functions to increase the amount of sugar excreted in urine.

Johnson & Johnson touted the diabetes medication as a cutting-edge, brand-new class of diabetes medicine, that would flush glucose out of the body and might even help patients lose weight.

However, the drug maker may have also made false statements about Invokana safety and concealed certain life-threatening risks associated with taking the drug.

Invokana has reportedly been associated with a deadly condition called ketoacidosis. This build-up of toxic acids in the blood is being observed with troubling frequency among users of Invokana.

Additionally, Invokana may pose an increased risk of heart attack and stroke, which could even be dangerously elevated the first month a patient takes the drug.

Still, despite this risks, the label for the drug carries no warnings about heart attacks, strokes, or the risk of developing ketoacidosis.

FDA Warns About Invokana

A little more than two years after Invokana’s introduction to the market, the FDA issued a warning about serious risks associated with Invokana and other similar SGLT2 inhibitors.

The FDA, in its May 2015 report, highlighted more than 20 adverse event reports linked to SGLT2 inhibitors, each of which resulted in hospitalization or emergency room treatment.

Problems associated with Invokana include kidney failure, kidney impairment, kidney stones, urinary tract infections and abnormal weight loss.

Short of mandating a label update, the FDA has cautioned patients to be aware of the potential link between Invokana and diabetic ketoacidosis – a condition in which high levels of acid accumulate in the blood.

Difficulty breathing, nausea or vomiting, abdominal pain, confusion, fatigue and sleeplessness are all symptoms of ketoacidosis.

Diabetic ketoacidosis can cause swelling of the brain, severe dehydration, coma and even death.

Despite the FDA warning about the risk of Invokana diabetic ketoacidosis, the drug continues to be prescribed to hundreds of thousands of new users.

Filing an Invokana Lawsuit

Hundreds of Invokana users and their families are beginning to file lawsuits against the drug manufacturers for allegedly making false statements about Invokana safety.

You may qualify to seek compensation if you have experienced any of the following symptoms after taking Invokana:

• Diabetic ketoacidosis (with symptoms including nausea and vomiting, abdominal pain, weakness, shortness of breath and confusion)
• Major cardiac event (such as heart attack or stroke), especially if suffered in the first month of using Invokana
• Kidney failure

Many who believed the false statements about Invokana safety have suffered these complications and had to undergo extensive medical treatment, including extended stays in the hospital and follow-up treatments.

If you have suffered severe complications after taking Invokana, an experienced dangerous drug attorney can help you in determining whether you can file a legal claim for compensation.

The Invokana Lawsuit is Case No. 3:16-cv-06143 in the U.S. District Court for the District of New Jersey, Trenton Division.